| 1 | ALG3
|
| ALG3 Is a Potential Biomarker for the Prognosis of Bladder Cancer.
|
| Li M, Zhang N, Shan W, Guan B.
|
| Ann Clin Lab Sci. Jan;52(1):117-125 2022
|
| 2 | ALG3, CDG1D
|
| ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.
|
| Farolfi M, Cechova A, Ondruskova N, Zidkova J, Kousal B, Hansikova H, Honzik T, Liskova P.
|
| BMC Ophthalmol. Jun 5;21(1):249. doi: 10.1186/s12886-021-02013-2. 2021
|
| 3 | ALG3, PPFIA1
|
| Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma
|
| Zhou H, Cao T, Li WP, Wu G.
|
| Mol Biol Rep. Jun;46(3):2693-2701. doi: 10.1007/s11033-019-04712-y. Epub 2019 Feb 25 2019
|
| 4 | ALG3, HSF2
|
| ALG3 Is Activated by Heat Shock Factor 2 and Promotes Breast Cancer Growth.
|
| Yang Y, Zhou Y, Xiong X, Huang M, Ying X, Wang M.
|
| Med Sci Monit. May 25;24:3479-3487. doi: 10.12659/MSM.907461. 2018
|
| 5 | ALG12, ALG3, CDG1A, CDG1B, CDG1D, CDG1G, CDG1J, CDG2B, DPAGT1, MOGS, MPI, PMM2
|
| Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation.
|
| Kane MS, Davids M, Adams C, Wolfe LA, Cheung HW, Gropman A, Huang Y; NISC Comparative Sequencing Program, Ng BG, Freeze HH, Adams DR, Gahl WA, Boerkoel CF.
|
| Am J Hum Genet 98(2):339-46. doi: 10.1016/j.ajhg.2015.12.007. Epub 2016 Jan 21.
2016
|
| 6 | ALG1, ALG3, ALG6, CDG1C, CDG1D, CDG1K, CDG1U, DPM2
|
| Electroclinical Features of Early-Onset Epileptic Encephalopathies in Congenital Disorders of Glycosylation (CDGs).
|
| Fiumara A, Barone R, Del Campo G, Striano P, Jaeken J.
|
| JIMD Rep IMD Rep. 2015 Oct 10. [Epub ahead of print]
2015
|
| 7 | ALG1, ALG3, ALG6, ALG8, ALG9, B4GALT1, CDG1C, CDG1D, CDG1H, CDG1K, CDG1L, CDG1U, CDG2E, CDG2F, CDG2G, CDG2H, CDG2I, CDG2M, COG1, COG5, COG7, COG8, DPM2, SLC35A2
|
| Congenital disorders of glycosylation with emphasis on cerebellar involvement.
|
| Barone R, Fiumara A, Jaeken J.
|
| Semin Neurol 34(3):357-66. doi: 10.1055/s-0034-1387197. Epub 2014 Sep 5. Review. 2014
|
| 8 | ALG1, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, CDG1A, CDG1B, CDG1C, CDG1D, CDG1E, CDG1F, CDG1G, CDG1H, CDG1I, CDG1J, CDG1K, CDG1L, CDG1N, CDG1O, DK1D, DOLK, DPAGT1, DPM1, DPM3, MPDU1, MPI, PMM2, RFT1
|
| Congenital disorders of glycosylation: An update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.
|
| Haeuptle MA, Hennet T.
|
| Hum Mutat um Mutat. 2009 Oct 27. [Epub ahead of print] 2009
|
| 9 | ALG3, CDG1D
|
| Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
|
| Rimella-Le-Huu A, Henry H, Kern I, Hanquinet S, Roulet-Perez E, Newman CJ, Superti-Furga A, Bonafé L, Ballhausen D.
|
| J Inherit Metab Dis Inherit Metab Dis. 2008 Aug 9. [Epub ahead of print]
2008
|
| 10 | ALG3,CDG1D
|
| CDG-Id in two siblings with partially different phenotypes.
|
| Kranz C, Sun L, Eklund EA, Krasnewich D, Casey JR, Freeze HH.
|
| Am J Med Genet A 143(13):1414-20. 2007
|
| 11 | ALG1, ALG12, ALG2, ALG3, ALG6, ALG8, ALG9, CDG1A, CDG1B, CDG1C, CDG1D, CDG1E, CDG1F, CDG1G, CDG1H, CDG1I, CDG1J, CDG1K, CDG1L, CDG2A, CDG2B, CDG2E, CDG2G, CDG2H, COG1, COG7, COG8, DPAGT1, DPM1, MGAT2, MOGS, MPDU1, MPI, PMM2
|
| Congenital disorders of N-glycosylation including diseases associated with O- as well as N-glycosylation defects.
|
| Leroy JG.
|
| Pediatr Res 60(6):643-56. Epub 2006 Oct 25. 2006
|
| 12 | CDG1D, CDG1E, ALG3
|
| Congenital disorder of glycosylation type Id: clinical phenotype, molecular analysis, prenatal diagnosis, and glycosylation of fetal proteins.
|
| Denecke J, Kranz C, von Kleist-Retzow JCh, Bosse K, Herkenrath P, Debus O, Harms E, Marquardt T.
|
| Pediatr Res 58(2):248-53. Epub 2005 Jul 8. 2005
|
| 13 | CDG1D, ALG3
|
| CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter).
|
| Schollen E, Grunewald S, Keldermans L, Albrecht B, Korner C, Matthijs G.
|
| Eur J Med Genet 48(2):153-8. Epub 2005 Feb 17. 2005
|
| 14 | ALG3, CDG1D
|
| Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase.
|
| Körner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K.
|
| EMBO J 18(23):6816-22.
1999
|